Literature DB >> 14522593

Enzymatic and transcriptional regulation of human ecto-ATPase/E-NTPDase 2.

Aileen F Knowles1, Wei-Chieh Chiang.   

Abstract

We have characterized the regulation of expressed human ecto-ATPase (E-NTPDase 2), a cell surface integral membrane glycoprotein. Ecto-ATPase activity is inhibited by parameters that decrease membrane protein interaction, i.e., detergents and high temperatures. These inhibitory effects are overcome when membranes are pretreated with concanavalin A or chemical cross-linking agents that increase the amounts of ecto-ATPase oligomers. Cross-linking agents also abrogate substrate inactivation of the ecto-ATPase, a unique characteristic of the enzyme. These effects indicate that the magnitude of negative substrate regulation is dependent on quaternary structures of the protein, which likely involves interaction of transmembrane domains. The importance of transmembrane domains of ecto-ATPase in activity modulation is demonstrated further by the stimulatory effect of digitonin, a steroid glycoside that preferentially interacts with cholesterol in the membranes but does not promote oligomer formation. These results indicate that ecto-ATPase activity is regulated by a multitude of mechanisms, some of which may have physiological significance. Ecto-ATPase is also susceptible to transcriptional regulation. Ecto-ATPase gene expression is increased in a human hepatoma whereas it is undetectable in the normal liver.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522593     DOI: 10.1016/j.abb.2003.08.007

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  22 in total

1.  Inhibition of ecto-ATPase activity by curcumin in hepatocellular carcinoma HepG2 cells.

Authors:  Takuto Fujii; Takuma Minagawa; Takahiro Shimizu; Noriaki Takeguchi; Hideki Sakai
Journal:  J Physiol Sci       Date:  2011-09-20       Impact factor: 2.781

2.  Generation and characterization of polyclonal and monoclonal antibodies to human NTPDase2 including a blocking antibody.

Authors:  Julie Pelletier; Hervé Agonsanou; Ninotchska Delvalle; Michel Fausther; Mabrouka Salem; Brian Gulbransen; Jean Sévigny
Journal:  Purinergic Signal       Date:  2017-04-13       Impact factor: 3.765

3.  A capillary electrophoresis method for the characterization of ecto-nucleoside triphosphate diphosphohydrolases (NTPDases) and the analysis of inhibitors by in-capillary enzymatic microreaction.

Authors:  Jamshed Iqbal; Petra Vollmayer; Norbert Braun; Herbert Zimmermann; Christa E Müller
Journal:  Purinergic Signal       Date:  2005-12-03       Impact factor: 3.765

4.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

5.  Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.

Authors:  Yael Nadel; Joanna Lecka; Yocheved Gilad; Gal Ben-David; Daniel Förster; Georg Reiser; Sarah Kenigsberg; Jean Camden; Gary A Weisman; Hanoch Senderowitz; Jean Sévigny; Bilha Fischer
Journal:  J Med Chem       Date:  2014-05-30       Impact factor: 7.446

Review 6.  The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.

Authors:  Guido Beldi; Keiichi Enjyoji; Yan Wu; Lindsay Miller; Yara Banz; Xiaofeng Sun; Simon C Robson
Journal:  Front Biosci       Date:  2008-01-01

7.  8-BuS-ATP derivatives as specific NTPDase1 inhibitors.

Authors:  Joanna Lecka; Irina Gillerman; Michel Fausther; Mabrouka Salem; Mercedes N Munkonda; Jean-Philippe Brosseau; Christine Cadot; Mireia Martín-Satué; Pedro d'Orléans-Juste; Eric Rousseau; Donald Poirier; Beat Künzli; Bilha Fischer; Jean Sévigny
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

8.  IL-6 downregulates transcription of NTPDase2 via specific promoter elements.

Authors:  Jin Yu; Elise G Lavoie; Nina Sheung; Jacques J Tremblay; Jean Sévigny; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-01-17       Impact factor: 4.052

9.  Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases).

Authors:  Younis Baqi; Stefanie Weyler; Jamshed Iqbal; Herbert Zimmermann; Christa E Müller
Journal:  Purinergic Signal       Date:  2008-06-05       Impact factor: 3.765

10.  Trafficking and intracellular ATPase activity of human ecto-nucleotidase NTPDase3 and the effect of ER-targeted NTPDase3 on protein folding.

Authors:  Vasily V Ivanenkov; Jean Sévigny; Terence L Kirley
Journal:  Biochemistry       Date:  2008-08-12       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.